InMode (NASDAQ:INMD - Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Monday, April 28th. Analysts expect InMode to post earnings of $0.45 per share and revenue of $82.21 million for the quarter.
InMode Stock Up 0.6 %
Shares of INMD stock traded up $0.09 during mid-day trading on Friday, hitting $16.22. 932,124 shares of the stock were exchanged, compared to its average volume of 1,173,996. InMode has a 52-week low of $13.68 and a 52-week high of $19.85. The company has a market cap of $1.13 billion, a PE ratio of 6.90 and a beta of 1.96. The firm has a fifty day moving average of $17.36 and a 200 day moving average of $17.62.
Wall Street Analyst Weigh In
INMD has been the topic of a number of recent analyst reports. Barclays increased their price target on InMode from $26.00 to $29.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 5th. Needham & Company LLC reiterated a "hold" rating on shares of InMode in a research report on Wednesday, April 9th. Finally, Jefferies Financial Group cut their price target on shares of InMode from $16.00 to $15.00 and set a "hold" rating for the company in a report on Monday, April 14th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $21.25.
View Our Latest Analysis on INMD
About InMode
(
Get Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
See Also
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
